Biomarkers of Cardiovascular disorders

Cardiovascular disease (CVD) remains the leading cause of death globally. The identification of traditional risk factors such as age, hypercholesterolemia, hypertension, diabetes mellitus, and smoking has improved primary prevention of CVD. Cardiac markers are measured biomarkers to assess cardiac function. They are often discussed in the context of myocardial infarction, but other conditions can lead to an elevation in the level of the cardiac marker. Cardiac biomarkers are elements that are released into the blood when the heart is damaged or strained. A cardiac marker is used in the identification and risk stratification of patients with chest pain and suspected acute coronary syndrome (ACS). These markers include enzymes, hormones and proteins. Cardiac biomarkers have evolved as essential tools in cardiology in the last 50 years, that is, for primary and secondary prevention, the diagnosis and treatment of acute myocardial infarction (AMI), and the diagnosis and stratification of the risk of heart failure.

    Related Conference of Biomarkers of Cardiovascular disorders

    October 25-26, 2019

    14th International Conference on Biopharma and Biotherapeutics

    | Copenhagen, Denmark
    October 23-24, 2019 | Copenhagen, Denmark

    12th Pharma Congress

    September 11-12, 2019

    2nd Annual Pharmaceutical Biotechnology Congress

    Singapore
    November 11-12, 2019

    20th Annual Pharma Middle East Congress

    Renaissance Polat Istanbul Hotel | Istanbul, Turkey
    November 18-19, 2019

    European Congress on Nanomedicine and Pharmaceutical Nanotechnology

    Prague, Czech Republic
    November 18-19, 2019

    European Conference on Pharmacovigilance & Drug Safety

    Prague, Czech Republic
    December 02, 03, 2019

    15th Annual Congress on Pharmacology and Toxicology

    Paris, France
    February 12-13, 2020

    14th Global Pharmacovigilance and Clinical Trials Summit

    Sydney, Australia
    February 12-13, 2020

    2nd International Conference on Biosimilars & Pharmaceuticals

    Auckland, New Zealand
    March 25-26, 2020

    23rd Asia Pacific Pharma Congress

    Singapore
    April 01-02, 2020

    13th European Biosimilars Congress 2020

    London, UK
    April 09-10, 2020

    World Pharma Expo

    Bangkok, Thailand
    April 27-28, 2020

    5th Pharmaceutical Chemistry Conference

    Prague, Czech Republic
    April 27-28, 2020

    7th European Biopharma Congress

    Prague, Czech Republic
    May 06-07, 2020

    15th Annual Meet on Euro Ethnopharmacology

    Prague | Czech Republic
    May 18-19, 2020

    30th Annual European Pharma Congress

    Berlin, Germany
    May 27- 28, 2020

    14 th World Drug Delivery Summit

    | London, UK
    June 15-16, 2020

    cancer-research-2020

    Barcelona, Spain
    August 26-27, 2020

    33rdWorld Congress on Pharmacology

    Barcelona, Spain
    September 07-08, 2020

    Global Summit on Generic Drugs and Quality Control

    | Prague, Czech Republic
    September 10-11, 2020

    World Congress on Rare Diseases & Orphan Drugs

    | Prague, Czech Republic
    September 21-22, 2020

    35th World Pharmacology and Toxicology Forum

    Tokyo, Japan
    October 19-20, 2020

    Innovation in Drug Design Techniques and Pharmacology

    | Paris, France
    December 02-03, 2020

    International Conference onBiotechnology and Healthcare

    Auckland, Newzealand
    December 06-07, 2021

    22nd Pharma Middle East Congress

    Dubai, UAE

    Biomarkers of Cardiovascular disorders Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in